Esther S Yoon

Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV‐1106, a Long‐Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects

Kazumasa Yamada, O. Spiegelstein, M. Bassan, 2016, Clinical pharmacology in drug development.

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

P. Loupe, E. Aycardi, O. Spiegelstein, 2018, Cephalalgia : an international journal of headache.

Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects

J. McCrea, S. Stoch, K. Furihata, 2022, Clinical pharmacology in drug development.

11th European Headache Federation Congress jointly with 31st Congress of the Italian Society for the Study of Headaches

E. Aycardi, O. Cohen‐Barak, P. Yeung, 2017, The Journal of Headache and Pain.

Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil

W. Kraft, J. McCrea, D. Panebianco, 2019, Journal of clinical pharmacology.

Safety, Tolerability, and Pharmacokinetic Evaluation of Single and Multiple Doses of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Healthy Japanese and White Adults

Jun Zou, H. Usansky, A. Teper, 2022, Clinical pharmacology in drug development.